KIMBERLY COWART: Open Payments
NPI 1649861139 · GREENVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,179 in 50 payments from 12 companies in 2025. Trend: 2023 $2,624 · 2024 $3,339 · 2025 $1,179
Food & beverage: $1,179
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 7 | $295 |
| ABBVIE INC. | 12 | $176 |
| Arcutis Biotherapeutics, Inc. | 3 | $135 |
| Regeneron Healthcare Solutions, Inc. | 4 | $103 |
| Novartis Pharmaceuticals Corporation | 4 | $102 |
| Janssen Biotech, Inc. | 5 | $90 |
| LEO Pharma Inc. | 3 | $61 |
| Organon LLC | 4 | $57 |
| E.R. Squibb & Sons, L.L.C. | 3 | $57 |
| Genentech USA, Inc. | 2 | $39 |
Products named: Bimzelx, Zoryve, RINVOQ, DUPIXENT, TREMFYA, ADBRY, Sotyktu, COSENTYX.
Industry payments across NC — which companies pay providers there.
